Sarcoma as a second malignancy after treatment for breast cancer

Area of Science:

• Oncology
• Radiation Oncology
• Cancer Epidemiology

Background:

• Radiotherapy for breast cancer can lead to secondary malignant neoplasms, including sarcomas.
• Previous studies on radiation-induced sarcomas in breast cancer patients were limited by small sample sizes.
• This study investigates the association between radiation therapy and subsequent sarcoma development in a large cohort of breast cancer patients.

Purpose of the Study:

• To evaluate the influence of radiation therapy on the development of subsequent sarcomas in primary breast cancer patients.
• To determine the cumulative incidence and survival rates of secondary sarcomas after breast cancer treatment.
• To identify specific sarcoma types associated with radiotherapy.

Main Methods:

• Utilized data from the Surveillance, Epidemiology and End Results (SEER) registries (1973-1997).
• Identified 274,572 cases of primary invasive breast cancer and 263 cases of subsequent sarcomas.
• Employed Kaplan-Meier methods to calculate cumulative incidence and survival post-secondary sarcoma diagnosis.

Main Results:

• The overall incidence of sarcoma was low, with a 15-year cumulative incidence of 3.2 per 1,000 for radiotherapy patients versus 2.3 per 1,000 for non-radiotherapy patients (p=0.001).
• Angiosarcoma was significantly more prevalent (56.8%) among sarcomas occurring within the radiation field compared to those not receiving radiotherapy (5.7%).
• Five-year survival for sarcoma post-breast cancer was poor (27-35%) and not significantly different between radiotherapy groups.

Conclusions:

• Breast cancer radiotherapy is associated with a small increase in subsequent sarcoma risk.
• Angiosarcoma is a notable type of sarcoma linked to radiotherapy, especially when occurring in or near the radiation field.
• The small increase in sarcoma risk does not negate the established benefits of radiotherapy for breast cancer treatment.